UHRF1 and colorectal carcinoma: In this case, we treated the engineered HCT116 human colorectal carcinoma cells with dox for 2 weeks (to generate hypomethylated genomes), terminated the dox treatment and then monitored DNA methylation recovery for 2 weeks as UHRF1 or DNMT1 expression was restored (Supplementary Figure S3A).